✦ LIBER ✦

Zolpidem in Parkinson's disease

✍ Scribed by Antonio Daniele; Alberto Albanese; Guido Gainotti; Bruno Gregori; Paolo Bartolomeo

Book ID: 119503484
Publisher: The Lancet
Year: 1997
Tongue: English
Weight: 25 KB
Volume: 349
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)62416-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ Jean Lavoisy; Jean Marsac 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 50 KB

Zolpidem: a new approach for Parkinson’s

Zolpidem: a new approach for Parkinson’s disease?

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 203 KB

Zolpidem improves akinesia, dystonia and

Zolpidem improves akinesia, dystonia and dyskinesia in advanced Parkinson’s disease

✍ Yen-Yu Chen; Hiu-Ngar Sy; Shey-Lin Wu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Subhypnotic doses of zolpidem oppose dop

Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease

✍ Evžen Růžička; Jan Roth; Robert Jech; Petr Bušek 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 572 KB

Parkinson's disease or Parkinson's disea

Parkinson's disease or Parkinson's diseases?

✍ Y. Agid 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Parkinson's Disease Volume 1052 || Parki

Parkinson's Disease Volume 1052 || Parkinson's Disease

✍ Penney, Ellen B. 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 7 KB

Parkinson’s disease is the second most prevalent neurodegenerative disease and is characterized by the irreversible loss of dopamine neurons. Despite its high prevalence in society and many decades of research, the origin of the pathogenesis and the molecular determinants involved in the disorder ha